Esclerose Múltipla e as Novas Abordagens Terapêuticas
MCS Sousa - ubibliorum.ubi.pt
A esclerose múltipla é uma doença crónica, auto-imune, inflamatória e neurodegenerativa
que afeta o sistema nervoso central. Nesta doença, o sistema imunitário não reconhece …
que afeta o sistema nervoso central. Nesta doença, o sistema imunitário não reconhece …
[PDF][PDF] Atousa Moghadam Fard
R Habibi, R Sarallah, G Majidi, M Khorami, F Dadgar… - researchgate.net
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous
system (CNS). In 2015, approximately 2.3 million people had MS in the world. The disease …
system (CNS). In 2015, approximately 2.3 million people had MS in the world. The disease …
[PDF][PDF] DE NODEN VAN DE OFFICINA-APOTHEKER BIJ DE BEGELEIDING VAN MS-PATIËNTEN
L Soete - libstore.ugent.be
Achtergrond: Multiple sclerose (MS) is een inflammatoire auto-immuunziekte van het
centraal zenuwstelsel en kent een complexe behandeling. De diagnose wordt gesteld door …
centraal zenuwstelsel en kent een complexe behandeling. De diagnose wordt gesteld door …
Neuro Rehab Times
N Putzki - nrtimes.co.uk
Over the last 30 years, remarkable progress has been made in the advancement of treating
multiple sclerosis (MS), a potentially disabling disease that is most likely a consequence of …
multiple sclerosis (MS), a potentially disabling disease that is most likely a consequence of …
Current perspectives on Multiple Sclerosis
S Çimen, K Küçükoğlu - NanoEra - dergipark.org.tr
Multiple Sclerosis (MS) is a chronic, autoimmune disease that affects the central nervous
system. It is characterised by inflammation, demyelination and axonal loss, and is typically …
system. It is characterised by inflammation, demyelination and axonal loss, and is typically …
[HTML][HTML] Dysregulated autotaxin expression by T cells in multiple sclerosis
CL Petersen-Cherubini, Y Liu, JL Deffenbaugh… - Journal of …, 2024 - Elsevier
Multiple sclerosis (MS) is a demyelinating disease characterized by infiltration of
autoreactive T cells into the central nervous system (CNS). In order to understand how …
autoreactive T cells into the central nervous system (CNS). In order to understand how …
[引用][C] Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First-Versus Second-or Later-Line Treatment With Ocrelizumab
CKGDS Tu, MTD Jones - 2023 - europepmc.org
Introduction: Prior research has demonstrated that early treatment with high-efficacy
diseasemodifying therapies (DMTs), including ocrelizumab (OCR), can reduce relapses and …
diseasemodifying therapies (DMTs), including ocrelizumab (OCR), can reduce relapses and …